A Study of the Relationship Between Cystatin C and Metabolic Bone Disease in Preterm Infants
Open Access
- 18 May 2018
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 10 (2) , 119-124
Abstract
Objective: Cystatin C (CysC) is commonly used as a marker of renal failure in premature infants. The aim of this study was to investigate serum CysC levels in osteopenia of prematurity (OP) and determine whether CysC could be safely used as a marker of renal insufficiency in infants with OP. Methods: Subjects were 50 preterm infants (<= 32 gestational weeks). Calcium (Ca), phosphorus (P) and alkaline phosphatase (ALP) serum levels were measured in postnatal week nine, and bone density was measured concurrently by quantitative ultrasonography. Patients with a Z score of <-2 were considered to have OP. Results: The mean serum CysC levels in preterm infants in postnatal week nine were 1.50 +/- 0.19 mg/L. Serum CysC levels were not correlated with speed of sound values, Z scores, serum Ca, P or ALP levels. Serum CysC levels were not significantly different between infants with OP 11.50 (1.35-1.61) mg/L] and in infants without OP 11.58 (1.28-1.70) mg/L]. Conclusion: The presence of OP does not affect the safety of CysC as a marker of renal insufficiency in preterm infants.Keywords
This publication has 38 references indexed in Scilit:
- Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signalingThe FASEB Journal, 2013
- Cystatin C and risk of hip fractures in older womenJournal of Bone and Mineral Research, 2013
- Serum cystatin C predicts acute kidney injury in preterm neonates with respiratory distress syndromePediatric Nephrology, 2012
- Determination of reference values for plasma cystatin C and comparison with creatinine in premature infantsPediatric Nephrology, 2008
- Cystatin‐C, Renal Function, and Incidence of Hip Fracture in Postmenopausal WomenJournal of the American Geriatrics Society, 2008
- Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formationBiochemical and Biophysical Research Communications, 2007
- Enteral calcium, phosphate and vitamin D requirements and bone mineralization in preterm infantsActa Paediatrica, 2007
- Quantitative ultrasound and biochemical parameters for the assessment of osteopenia in preterm infantsThe Journal of Maternal-Fetal & Neonatal Medicine, 2007
- Cystatin C versus creatinine as a marker of glomerular filtration rate in the newbornWiener klinische Wochenschrift, 2006
- Quantitative Bone Analysis in Children: Current Methods and RecommendationsThe Journal of Pediatrics, 2005